A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Nature Medicine │ 2019

Alexander C. Huang; Robert J. Orlowski; Xiaowei Xu; Rosemarie Mick; Sangeeth M. George; Patrick K. Yan; Sasikanth Manne; Adam A. Krava; Bradley Wubbenhorst; Liza Dorfman; Kurt D’Andrea; Brandon M. Wenz; Shujing Liu; Lakshmi Chilukurt; Andrew Kozlov; Mary Carberry; Lydia Giles; Melanie W. Kier; Felix Quagliarello; Suzanne McGettigan; Kristin Kreider; Lakshmanan Annamalai; Qing Zhao; Robin Mogg; Wei Xu; Wendy Blumenschiein; Jennifer H. Yearley; Gerald P. Linette; Ravi K. Amaravadi; Lynn M. Schuchter; Ramin S. Herati; Bertram Bengsch; Katherine L. Nathanson; Michael D. Farwell; Giorgos C. Karakousis; E. John Wherry; Tara Mitchell